186 related articles for article (PubMed ID: 11176586)
1. In vitro and in vivo antimicrobial activity of topical ofloxacin and other ototopical agents.
Klein JO
Pediatr Infect Dis J; 2001 Jan; 20(1):102-3; discussion 120-2. PubMed ID: 11176586
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ofloxacin and other otic preparations for acute otitis media in patients with tympanostomy tubes.
Goldblatt EL
Pediatr Infect Dis J; 2001 Jan; 20(1):116-9; discussion 120-2. PubMed ID: 11176590
[TBL] [Abstract][Full Text] [Related]
3. Ofloxacin otic solution: a review of its use in the management of ear infections.
Simpson KL; Markham A
Drugs; 1999 Sep; 58(3):509-31. PubMed ID: 10493278
[TBL] [Abstract][Full Text] [Related]
4. Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes.
Roland PS; Kreisler LS; Reese B; Anon JB; Lanier B; Conroy PJ; Wall GM; Dupre SJ; Potts S; Hogg G; Stroman DW; McLean C
Pediatrics; 2004 Jan; 113(1 Pt 1):e40-6. PubMed ID: 14702493
[TBL] [Abstract][Full Text] [Related]
5. Topical ofloxacin versus systemic amoxicillin/clavulanate in purulent otorrhea in children with tympanostomy tubes.
Goldblatt EL; Dohar J; Nozza RJ; Nielsen RW; Goldberg T; Sidman JD; Seidlin M
Int J Pediatr Otorhinolaryngol; 1998 Nov; 46(1-2):91-101. PubMed ID: 10190709
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ofloxacin and other ototopical preparations for chronic suppurative otitis media in children.
Bluestone CD
Pediatr Infect Dis J; 2001 Jan; 20(1):111-5; discussion 120-2. PubMed ID: 11176589
[TBL] [Abstract][Full Text] [Related]
7. Strategies for decreasing multidrug antibiotic resistance: role of ototopical agents for treatment of middle ear infections.
Klein JO
Am J Manag Care; 2002 Oct; 8(14 Suppl):S345-52. PubMed ID: 12408220
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of the effectiveness of ofloxaxin otic solution for the treatment of suppurative otitis media.
Abes G; Espallardo N; Tong M; Subramaniam KN; Hermani B; Lasiminigrum L; Anggraeni R
ORL J Otorhinolaryngol Relat Spec; 2003; 65(2):106-16. PubMed ID: 12824733
[TBL] [Abstract][Full Text] [Related]
9. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
Schwartz RH
Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: a multicenter, open-label, phase III trial.
Torum B; Block SL; Avila H; Montiel F; Oliva A; Quintanilla W; Duncanson F; Cantrell HF; Riefler J; Katz E; Lombardy E
Clin Ther; 2004 Jul; 26(7):1046-54. PubMed ID: 15336469
[TBL] [Abstract][Full Text] [Related]
11. Trimethoprim-sulfamethoxazole plus topical antibiotics as therapy for acute otitis media with otorrhea caused by community-acquired methicillin-resistant Staphylococcus aureus in children.
Al-Shawwa BA; Wegner D
Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):782-4. PubMed ID: 16172354
[TBL] [Abstract][Full Text] [Related]
12. The treatment of chronic suppurative otitis media and otitis externa with 0.3 per cent ofloxacin otic solution: a clinico-microbiological study.
Supiyaphun P; Tonsakulrungruang K; Chochaipanichnon L; Chongtateong A; Samart Y
J Med Assoc Thai; 1995 Jan; 78(1):18-21. PubMed ID: 7622972
[TBL] [Abstract][Full Text] [Related]
13. Ofloxacin otic solution for treatment of otitis externa in children and adults.
Jones RN; Milazzo J; Seidlin M
Arch Otolaryngol Head Neck Surg; 1997 Nov; 123(11):1193-200. PubMed ID: 9366699
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial of ototopical ofloxacin for treatment of chronic suppurative otitis media.
Agro AS; Garner ET; Wright JW; Caballeros de Escobar I; Villeda B; Seidlin M
Clin Ther; 1998; 20(4):744-59. PubMed ID: 9737834
[TBL] [Abstract][Full Text] [Related]
15. [Tympanostomy tube otorrhea: microbiological epidemiology, pathogen susceptibility to local antibiotics and bactericidal power of the rifamycin-olfloxacin combination].
François M; Mariani-Kurkdjian P; Doit C; Benzekri P; Bingen E; Macé JG
Ann Otolaryngol Chir Cervicofac; 2001 Oct; 118(5):278-82. PubMed ID: 11845035
[TBL] [Abstract][Full Text] [Related]
16. An economic evaluation of two ototopical treatments for acute otitis media in tympanostomy tube patients.
Roland PS; Waycaster CR; Wall GM; Glass JD
Value Health; 2006; 9(4):219-26. PubMed ID: 16903991
[TBL] [Abstract][Full Text] [Related]
17. A benefit-risk assessment of ofloxacin otic solution in ear infection.
Wai TK; Tong MC
Drug Saf; 2003; 26(6):405-20. PubMed ID: 12688832
[TBL] [Abstract][Full Text] [Related]
18. [Antimicrobial activity of ofloxacin against recent clinical isolates from otitis media and otitis externa].
Matsumoto Y; Suzuki Y; Ishii Y; Ishihara R; Nakazawa A; Nakane Y; Nishinari C; Deguchi K
Jpn J Antibiot; 1998 Sep; 51(9):561-75. PubMed ID: 9846283
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of ofloxacin in chronic otitis media and chronic sinusitis in adult outpatients.
Gehanno P; Cohen B
Eur Arch Otorhinolaryngol; 1993; 250 Suppl 1():S13-4. PubMed ID: 8476579
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of ototopical drops against middle ear pathogens.
Ikeda K; Takasaka T
Am J Otol; 1993 Mar; 14(2):170-1. PubMed ID: 8389100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
